• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖、炎症与心血管风险。

Obesity, inflammation, and cardiovascular risk.

机构信息

Quebec Heart and Lung Institute/Research Center, Québec, Québec, Canada.

出版信息

Clin Pharmacol Ther. 2010 Apr;87(4):407-16. doi: 10.1038/clpt.2009.311. Epub 2010 Mar 3.

DOI:10.1038/clpt.2009.311
PMID:20200516
Abstract

Obesity, a highly prevalent condition, is heterogeneous with regard to its impact on cardiovascular disease (CVD) risk. Epidemiological observations and metabolic investigations have consistently demonstrated that the accumulation of excess visceral fat is related to an increased risk of CVD as well as several metabolic and inflammatory perturbations. In the past decade, data from several studies have served to emphasize that atherosclerosis has an inflammatory component that may contribute to several key pathophysiological processes. Study data have also highlighted the finding that the expanded visceral fat is infiltrated by macrophages that conduct "cross-talk" with adipose tissue through several significant mechanisms. In this review, we provide, in the context of CVD risk, an up-to-date account of the complex interactions that occur between a dysfunctional adipose tissue phenotype and inflammation.

摘要

肥胖是一种高发疾病,其对心血管疾病(CVD)风险的影响存在异质性。流行病学观察和代谢研究一致表明,过多内脏脂肪的积累与 CVD 风险增加以及多种代谢和炎症紊乱有关。在过去的十年中,来自多项研究的数据强调了动脉粥样硬化具有炎症成分,可能有助于几个关键的病理生理过程。研究数据还突出了这样一个发现,即扩张的内脏脂肪被巨噬细胞浸润,巨噬细胞通过几种重要机制与脂肪组织进行“交叉对话”。在这篇综述中,我们根据 CVD 风险,提供了一个最新的关于功能失调的脂肪组织表型和炎症之间发生的复杂相互作用的描述。

相似文献

1
Obesity, inflammation, and cardiovascular risk.肥胖、炎症与心血管风险。
Clin Pharmacol Ther. 2010 Apr;87(4):407-16. doi: 10.1038/clpt.2009.311. Epub 2010 Mar 3.
2
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.腹部肥胖与代谢综合征:对全球心血管代谢风险的影响
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. doi: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20.
3
Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.腹型肥胖:2型糖尿病和心血管疾病的一个未治疗的危险因素。
J Endocrinol Invest. 2006;29(3 Suppl):77-82.
4
Molecular basis of obesity and the risk for cardiovascular disease.肥胖与心血管疾病风险的分子基础。
Herz. 2006 May;31(3):200-6. doi: 10.1007/s00059-006-2801-2.
5
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.脂肪组织的致病潜力以及脂肪细胞肥大和内脏脂肪增多的代谢后果。
Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68. doi: 10.1586/14779072.6.3.343.
6
Endothelial dysfunction in obesity: etiological role in atherosclerosis.肥胖中的内皮功能障碍:在动脉粥样硬化中的病因学作用。
Curr Opin Endocrinol Diabetes Obes. 2007 Oct;14(5):365-9. doi: 10.1097/MED.0b013e3282be90a8.
7
Is visceral obesity the cause of the metabolic syndrome?内脏肥胖是代谢综合征的病因吗?
Ann Med. 2006;38(1):52-63. doi: 10.1080/07853890500383895.
8
The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.心理应激的炎症后果:与胰岛素抵抗、肥胖、动脉粥样硬化及II型糖尿病的关系
Med Hypotheses. 2006;67(4):879-91. doi: 10.1016/j.mehy.2006.04.008. Epub 2006 Jun 15.
9
Adipose tissue, inflammation, and cardiovascular disease.脂肪组织、炎症与心血管疾病。
Circ Res. 2005 May 13;96(9):939-49. doi: 10.1161/01.RES.0000163635.62927.34.
10
Visceral adipose tissue and atherosclerosis.内脏脂肪组织与动脉粥样硬化。
Curr Vasc Pharmacol. 2009 Apr;7(2):169-79. doi: 10.2174/157016109787455680.

引用本文的文献

1
Sedentary-related abdominal fat accumulation reduced by administrating heat-treated -derived postbiotic.通过给予热处理衍生的后生元可减少与久坐相关的腹部脂肪堆积。
Front Nutr. 2025 Jul 15;12:1612804. doi: 10.3389/fnut.2025.1612804. eCollection 2025.
2
Calcium/Calmodulin-Dependent Protein Kinase II Inhibitors Mitigate High-Fat Diet-Induced Obesity in Mice.钙/钙调蛋白依赖性蛋白激酶II抑制剂减轻高脂饮食诱导的小鼠肥胖。
J Obes. 2025 Jun 30;2025:5530467. doi: 10.1155/jobe/5530467. eCollection 2025.
3
The role of immune checkpoints PD-1 and CTLA-4 in cardiovascular complications leading to heart failure.
免疫检查点蛋白PD-1和CTLA-4在导致心力衰竭的心血管并发症中的作用。
Front Immunol. 2025 Apr 4;16:1561968. doi: 10.3389/fimmu.2025.1561968. eCollection 2025.
4
Metabolic diseases in the East Asian populations.东亚人群中的代谢性疾病。
Nat Rev Gastroenterol Hepatol. 2025 Apr 8. doi: 10.1038/s41575-025-01058-8.
5
Casual correlation between overweight, obesity, and severe COVID-19 infection with respiratory failure: A two-sample Mendelian randomization.超重、肥胖与伴有呼吸衰竭的重症新型冠状病毒肺炎感染之间的偶然关联:一项两样本孟德尔随机化研究
Medicine (Baltimore). 2025 Jan 3;104(1):e41006. doi: 10.1097/MD.0000000000041006.
6
Increased plasma lipopolysaccharide-binding protein and altered inflammatory mediators reveal a pro-inflammatory state in overweight women.血浆脂多糖结合蛋白增加和炎症介质改变揭示超重女性存在促炎状态。
BMC Womens Health. 2025 Feb 10;25(1):57. doi: 10.1186/s12905-025-03588-4.
7
Obesity modulates NK cell activity via LDL and DUSP1 signaling for populations with adverse social determinants.肥胖通过低密度脂蛋白(LDL)和双特异性磷酸酶1(DUSP1)信号通路调节具有不良社会决定因素人群的自然杀伤(NK)细胞活性。
JCI Insight. 2024 Dec 24;10(2):e180606. doi: 10.1172/jci.insight.180606.
8
Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4-]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Associated Steatohepatitis.[1,2,5]恶二唑并[3,4 -]吡啶 - 7 - 醇作为线粒体解偶联剂用于治疗肥胖症和代谢功能障碍相关脂肪性肝炎的设计、合成及生物学评价
J Med Chem. 2024 Dec 12;67(23):21486-21504. doi: 10.1021/acs.jmedchem.4c02366. Epub 2024 Nov 30.
9
Neck circumference, waist-to-height ratio, Chinese visceral adiposity index and incident heart failure.颈围、腰高比、中国内脏肥胖指数与心力衰竭事件。
Nutr J. 2024 Nov 28;23(1):149. doi: 10.1186/s12937-024-01048-7.
10
Overview of the therapeutic efficacy of marine fish oil in managing obesity and associated metabolic disorders.海洋鱼油在治疗肥胖症及相关代谢紊乱中的疗效概述。
Physiol Rep. 2024 Oct;12(19):e70019. doi: 10.14814/phy2.70019.